Clinuvel Pharmaceuticals Ltd (CUVL) › Net IncomeClinuvel Pharmaceuticals Ltd (CUVL): Net IncomeAnnual figures by period end, from SEC filings.$23.18MYear ended 2026-06-30$23.35M2024-06-30: $23.35M2025-06-30: $23.12M2026-06-30: $23.18M$23.18M2024-06-30 Net Income (USD) 2026-06-30Period endedNet IncomeChange YoYSource filing2026-06-30$23.18M+0.2%2026-10-30, From 2025-07-012025-06-30$23.12M-1.0%2026-10-30, From 2024-07-012024-06-30$23.35Mn/a2026-10-30, From 2023-07-01Other metrics: RevenueCost of RevenueGross ProfitR&D ExpenseOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresFree Cash FlowShare RepurchasesDividends PaidShares OutstandingWeighted Average Diluted SharesEPS (Basic)